| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A New Standard in Graft-versus-Host Disease Prophylaxis? An Introduction to Blood and Marrow Transplant Clinical Trials Network 1703
|
DeFilipp, Zachariah
|
|
|
26 |
12 |
p. e305-e308
|
artikel
|
| 2 |
A Pilot Study of Lenalidomide Maintenance Therapy after Autologous Transplantation in Relapsed or Refractory Classical Hodgkin Lymphoma
|
Shea, Lauren
|
|
|
26 |
12 |
p. 2223-2228
|
artikel
|
| 3 |
Australasian Trends in Allogeneic Stem Cell Transplantation for Myelofibrosis in the Molecular Era: A Retrospective Analysis from the Australasian Bone Marrow Transplant Recipient Registry
|
Lwin, Yadanar
|
|
|
26 |
12 |
p. 2252-2261
|
artikel
|
| 4 |
Barriers to Hematopoietic Cell Transplantation for Adults in the United States: A Systematic Review with a Focus on Age
|
Flannelly, Colin
|
|
|
26 |
12 |
p. 2335-2345
|
artikel
|
| 5 |
BEAM-Campath Allogeneic Stem Cell Transplant for Patients with Relapsed/Refractory Lymphoma: High Incidence of Long-Term Mixed Donor-Recipient Chimerism and the Response to Donor Lymphocyte Infusions
|
Burney, Claire
|
|
|
26 |
12 |
p. 2271-2278
|
artikel
|
| 6 |
Cardiovascular Events Associated with Chimeric Antigen Receptor T Cell Therapy: Cross-Sectional FDA Adverse Events Reporting System Analysis
|
Guha, Avirup
|
|
|
26 |
12 |
p. 2211-2216
|
artikel
|
| 7 |
Clinical and Neuroimaging Correlates of Post-Transplant Delirium
|
Smith, Patrick
|
|
|
26 |
12 |
p. 2323-2328
|
artikel
|
| 8 |
Clinical-Grade Expanded Regulatory T Cells Are Enriched with Highly Suppressive Cells Producing IL-10, Granzyme B, and IL-35
|
Ulbar, Francesca
|
|
|
26 |
12 |
p. 2204-2210
|
artikel
|
| 9 |
Costs of Cord Blood Transplantation Are Higher Than Other Graft Sources in Patients with Acute Leukemia and Myelodysplastic Syndrome Treated at Pediatric Centers
|
Rangarajan, Hemalatha G.
|
|
|
26 |
12 |
p. e313-e315
|
artikel
|
| 10 |
Early Mixed Lymphoid Donor/Host Chimerism is Associated with Improved Transplant Outcome in Patients with Primary or Secondary Myelofibrosis
|
Deeg, H. Joachim
|
|
|
26 |
12 |
p. 2197-2203
|
artikel
|
| 11 |
Editorial Board
|
|
|
|
26 |
12 |
p. A2
|
artikel
|
| 12 |
Goal-Oriented Monitoring of Cyclosporine Is Effective for Graft-versus-Host Disease Prevention after Hematopoietic Stem Cell Transplantation in Sickle Cell Disease and Thalassemia Major
|
Gauthier, Alexandra
|
|
|
26 |
12 |
p. 2285-2291
|
artikel
|
| 13 |
Guidelines for Cord Blood Unit Selection
|
Politikos, Ioannis
|
|
|
26 |
12 |
p. 2190-2196
|
artikel
|
| 14 |
Haploidentical Stem Cell Transplantation with Post-Transplant Cyclophosphamide in Fanconi Anemia: Improving Outcomes with Improved Supportive Care in India
|
Uppuluri, Ramya
|
|
|
26 |
12 |
p. 2292-2298
|
artikel
|
| 15 |
Health-Related Quality-of-Life Comparison of Adult Related and Unrelated HSC Donors: An RDSafe Study
|
Switzer, Galen E.
|
|
|
26 |
12 |
p. 2365-2371
|
artikel
|
| 16 |
Impact of CD34 Cell Dose and Conditioning Regimen on Outcomes after Haploidentical Donor Hematopoietic Stem Cell Transplantation with Post-Transplantation Cyclophosphamide for Relapsed/Refractory Severe Aplastic Anemia
|
Arcuri, Leonardo Javier
|
|
|
26 |
12 |
p. 2311-2317
|
artikel
|
| 17 |
Impact of Donor Source on Allogeneic Hematopoietic Stem Cell Transplantation for Mature T Cell and Natural Killer Cell Neoplasms in the Kyoto Stem Cell Transplantation Group
|
Watanabe, Mizuki
|
|
|
26 |
12 |
p. 2346-2358
|
artikel
|
| 18 |
Impact of Mixed Chimerism on Myelofibrosis Outcomes after Allogeneic Hematopoietic Stem Cell Transplantation
|
Srour, Samer A.
|
|
|
26 |
12 |
p. e301-e302
|
artikel
|
| 19 |
Improving Hematopoietic Stem Cell Transplant in the Elderly: Can We Finally Start to Impact Nonrelapse Mortality?
|
Knight, Thomas G.
|
|
|
26 |
12 |
p. e303-e304
|
artikel
|
| 20 |
Incidence and Outcome of Late Relapse after Allogeneic Stem Cell Transplantation for Myelofibrosis
|
Atagunduz, Isik Kaygusuz
|
|
|
26 |
12 |
p. 2279-2284
|
artikel
|
| 21 |
Individuals, Boundaries, and Graft-versus-Host Disease
|
Deeg, H. Joachim
|
|
|
26 |
12 |
p. e309-e312
|
artikel
|
| 22 |
Letter to the Editor Regarding “Comparing Efficacy, Safety, and Preinfusion Period of Axicabtagene Ciloleucel versus Tisagenlecleucel in Relapsed/Refractory Large B Cell Lymphoma”
|
Zhang, Jie
|
|
|
26 |
12 |
p. e333-e334
|
artikel
|
| 23 |
Masthead (Purpose and Scope)
|
|
|
|
26 |
12 |
p. A1
|
artikel
|
| 24 |
Nonmyeloablative Conditioning Regimen before T Cell Replete Haploidentical Transplantation with Post-Transplant Cyclophosphamide for Advanced Hodgkin and Non-Hodgkin Lymphomas
|
Montes de Oca, Catalina
|
|
|
26 |
12 |
p. 2299-2305
|
artikel
|
| 25 |
Officers and Directors of ASTCT
|
|
|
|
26 |
12 |
p. A3
|
artikel
|
| 26 |
Outcome of Allogeneic Hematopoietic Cell Transplantation after Venetoclax and Hypomethylating Agent Therapy for Acute Myelogenous Leukemia
|
Sandhu, Karamjeet S.
|
|
|
26 |
12 |
p. e322-e327
|
artikel
|
| 27 |
Outcomes of Autologous Stem Cell Transplant Consolidation in Primary Central Nervous System Lymphoma: A Mayo Clinic Experience
|
Khurana, Arushi
|
|
|
26 |
12 |
p. 2217-2222
|
artikel
|
| 28 |
Outcomes with Autologous or Allogeneic Stem Cell Transplantation in Patients with Plasma Cell Leukemia in the Era of Novel Agents
|
Lemieux, Christopher
|
|
|
26 |
12 |
p. e328-e332
|
artikel
|
| 29 |
Peritransplantation Use of Ruxolitinib in Myelofibrosis
|
Ibrahim, Uroosa
|
|
|
26 |
12 |
p. 2177-2180
|
artikel
|
| 30 |
Posterior Reversible Encephalopathy Syndrome after Allogeneic Stem Cell Transplantation in Pediatric Patients with Fanconi Anemia, a Prospective Study
|
Behfar, Maryam
|
|
|
26 |
12 |
p. e316-e321
|
artikel
|
| 31 |
Predicting Survival after Allogeneic Hematopoietic Cell Transplantation in Myelofibrosis: Performance of the Myelofibrosis Transplant Scoring System (MTSS) and Development of a New Prognostic Model
|
Hernández-Boluda, Juan-Carlos
|
|
|
26 |
12 |
p. 2237-2244
|
artikel
|
| 32 |
Pre-Hematopoietic Stem Cell Transplantation Lung Computed Tomography as an Alternative to the Pulmonary Function Test during the COVID-19 Pandemic
|
Tamaki, Masaharu
|
|
|
26 |
12 |
p. 2318-2322
|
artikel
|
| 33 |
Prognostic Impact of Cytogenetic Evolution on the Outcome of Allogeneic Stem Cell Transplantation in Patients with Acute Myeloid Leukemia in Nonremission: A Single-Institute Analysis of 212 Recipients
|
Yuasa, Mitsuhiro
|
|
|
26 |
12 |
p. 2262-2270
|
artikel
|
| 34 |
Propylene Glycol-Free Melphalan versus PG-Melphalan as Conditioning for Autologous Hematopoietic Cell Transplantation for Myeloma
|
Monahan, Kathleen
|
|
|
26 |
12 |
p. 2229-2236
|
artikel
|
| 35 |
Real-World Issues and Potential Solutions in Hematopoietic Cell Transplantation during the COVID-19 Pandemic: Perspectives from the Worldwide Network for Blood and Marrow Transplantation and Center for International Blood and Marrow Transplant Research Health Services and International Studies Committee
|
Algwaiz, Ghada
|
|
|
26 |
12 |
p. 2181-2189
|
artikel
|
| 36 |
Response to Letter to Editor Regarding “Comparing Efficacy, Safety, and Preinfusion Period of Axicabtagene Ciloleucel versus Tisagenlecleucel in Relapsed/Refractory Large B Cell Lymphoma”
|
Oluwole, Olalekan O.
|
|
|
26 |
12 |
p. e335-e336
|
artikel
|
| 37 |
Single-Agent Cyclosporine for Graft-versus-Host Disease Prophylaxis in Patients with Acquired Aplastic Anemia Receiving Fludarabine-Based Conditioning
|
Iftikhar, Raheel
|
|
|
26 |
12 |
p. 2245-2251
|
artikel
|
| 38 |
Table of Contents
|
|
|
|
26 |
12 |
p. A4-A10
|
artikel
|
| 39 |
The Effect of Granulocyte Colony-Stimulating Factor Use on Hospital Length of Stay after Allogeneic Hematopoietic Cell Transplantation: A Retrospective Multicenter Cohort Study
|
George, Gemlyn
|
|
|
26 |
12 |
p. 2359-2364
|
artikel
|
| 40 |
The Global State of Hematopoietic Cell Transplantation for Multiple Myeloma: An Analysis of the Worldwide Network of Blood and Marrow Transplantation Database and the Global Burden of Disease Study
|
Cowan, Andrew J.
|
|
|
26 |
12 |
p. 2372-2377
|
artikel
|
| 41 |
Thrombotic Microangiopathy after Post-Transplantation Cyclophosphamide-Based Graft-versus-Host Disease Prophylaxis
|
Imus, Philip H.
|
|
|
26 |
12 |
p. 2306-2310
|
artikel
|
| 42 |
Use of Potentially Inappropriate Medications in Older Allogeneic Hematopoietic Cell Transplantation Recipients
|
Bhargava, Divya
|
|
|
26 |
12 |
p. 2329-2334
|
artikel
|
Tijdschrift beschrijving